美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

減肥藥

1,289.82

+40.123.21%

漲家數：5

跌家數：2

平家數：- -

市盈率：- -

高：1,301.32

開：1,249.67

低：1,249.67

收：1,249.70

資料載入中...

輝瑞4月23日成交額為11.45億美元

安進4月23日成交額為7.46億美元

Viking Therapeutics Inc 報告截至 3 月 31 日的季度業績 - 收益摘要

Viking Therapeutics Inc 報告截至 3 月 31 日的季度業績 - 收益摘要

市場消息：輝瑞公司在2025年美國臨牀腫瘤學會年會上提出癌症治療未來的大膽願景。

全球製藥巨頭起訴藥企仿製其減肥神藥

斯洛伐克總理暫停購買 COVID-19 疫苗，等待審查

碩迪生物盤中異動股價大漲5.03%報24.20美元

Viking Therapeutics, Inc.盤中異動早盤急速拉昇5.02%報26.76美元

諾和諾德盤中異動股價大漲3.66%

Altimmune, Inc.盤中異動急速拉昇5.57%

諾和諾德4月22日成交額為6.98億美元

安進4月22日成交額為5.77億美元

歐股“十一羅漢”收盤播報｜諾和諾德收跌超7.4%，歐萊雅則漲6.3%

碩迪生物盤中異動股價大跌5.37%

明晟公司MSCI北歐國家指數微幅下跌，報326.01點，北歐醫療保健板塊領跌。諾和諾德跌7.4%，在一眾成分股裏表現最差。

Viking Therapeutics, Inc.盤中異動快速上漲5.02%

諾和諾德盤中異動股價大漲3.00%報60.08美元

“減肥神藥”邁向口服時代！諾和諾德申請美國批准口服版Wegovy

諾和諾德股價下跌9.8%。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4599/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"減肥藥","latestPrice":1289.8245,"timestamp":1746215999999,"preClose":1249.7039,"halted":0,"volume":75845285,"delay":0,"changeRate":0.032104,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":40.120605,"latestTime":"05-02 16:00:00 EDT","open":1249.6709,"high":1301.315,"low":1249.6709,"amount":8375367350.76205,"amplitude":0.041325,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.931939,"peRate":32.937129,"turnoverRate":0.00718,"increases":5,"decrements":2,"flats":0,"marketCap":1381836112544,"floatMarketCap":1292379014240},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1301.315,"amplitude":0.041325,"preClose":1249.7039,"low":1249.6709,"pbRate":"9.931939","latestPrice":1289.8245,"volume":75845285,"delay":0,"open":1249.6709,"prevYearClose":1305.0607,"prevWeekClose":1313.4298,"prevMonthClose":1353.2255,"prevQuarterClose":1314.3724,"fiveDayClose":1313.4298,"twentyDayClose":1265.6132,"sixtyDayClose":1394.0055,"secType":"PLATE","market":"US","turnoverRate":0.00718,"peRate":32.937129,"marketCap":1381836112544,"floatMarketCap":1292379014240,"timestamp":1746215999999,"nameCN":"減肥藥"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":5,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529460611","title":"輝瑞4月23日成交額為11.45億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529460611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529460611?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 10:16","pubTimestamp":1745460984,"startTime":"0","endTime":"0","summary":"美东时间2025年4月23日，辉瑞成交额为11.45亿美元，成交额较昨日增加41.51%，当日成交量为5078.10万股。辉瑞于2025年4月23日跌0.62%，报22.39美元，该股过去5个交易日跌0.22%，年初至今跌14.21%，过去60日跌16.64%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-23|11.45亿|41.51%|5078.10万|#|2025-04-22|8.09亿|14.76%|3605.26万|#|2025-04-21|7.05亿|-41.56%|3202.10万|#|2025-04-17|12.06亿|44.24%|5407.37万|#|2025-04-16|8.36亿|-28.41%|3764.12万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424101630a464ab9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424101630a464ab9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999002232.USD","IE000M9KFDE8.USD","LU0868494617.USD","LU1894683264.USD","IE00BLSP4239.USD","SGXZ57979304.SGD","IE00BLSP4452.SGD","LU0321505439.SGD","BK4568","LU0234572021.USD","LU1057294990.SGD","BK4534","PFE","IE00B19Z3581.USD","LU0058720904.USD","LU0456855351.SGD","SG9999002224.SGD","BK4599","LU0289739699.SGD","BK4007","LU0985481810.HKD","SG9999011175.SGD","SG9999013999.USD","LU0170899867.USD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4588","BK4585","LU0306807586.USD","IE0002270589.USD","BK4533","BK4581","LU1883839398.USD","LU1023059063.AUD","BK4592","IE00BBT3K403.USD","LU0306806265.USD","SG9999001176.SGD","LU0225284248.USD","LU1066053197.SGD","LU1066051498.USD","SG9999003800.SGD","SG9999001176.USD","LU0225771236.USD","LU1894683348.USD","BK4550"],"gpt_icon":1},{"id":"2529697935","title":"安進4月23日成交額為7.46億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529697935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529697935?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 09:15","pubTimestamp":1745457352,"startTime":"0","endTime":"0","summary":"美东时间2025年4月23日，安进成交额为7.46亿美元，成交额较昨日增加29.32%，当日成交量为267.96万股。安进于2025年4月23日跌0.18%，报277.9美元，该股过去5个交易日跌5.89%，年初至今涨7.48%，过去60日跌0.99%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424091558a464995d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424091558a464995d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2242652126.USD","LU2112291526.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","LU0109394709.USD","LU2089984988.USD","AMGN","LU0289739699.SGD","BK4139","LU1061106388.HKD","IE0009355771.USD","LU1057294990.SGD","LU2468319806.SGD","LU1023059063.AUD","SG9999001440.SGD","IE00BJT1NW94.SGD","LU0320765992.SGD","BK4588","LU0058720904.USD","IE00B2B36J28.USD","BK4599","BK4533","LU0122379950.USD","LU0868494617.USD","IE00BFTCPJ56.SGD","LU1571399168.USD","LU1983299246.USD","BK4581","IE00BJJMRZ35.SGD","IE0002141913.USD","LU2242646821.SGD","BK4534","BK4566","BK4585"],"gpt_icon":0},{"id":"2529916663","title":"Viking Therapeutics Inc 報告截至 3 月 31 日的季度業績 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2529916663","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529916663?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 04:38","pubTimestamp":1745440681,"startTime":"0","endTime":"0","summary":"Viking Therapeutics Inc 报告截至 3 月 31 日的季度业绩 - 收益摘要Viking Therapeutics Inc VKTX.OQ报告，截至3月31日的季度调整后每股亏损41美分，低于去年同期的每股收益-26美分。报告收入为零；分析师预期为零。Viking Therapeutics Inc 报告的季度每股收益为亏损 41 美分。该公司当季亏损 4563 万美元。Viking Therapeutics Inc 本季度股价上涨了 5.5%，今年迄今为止亏损了 36.7%。华尔街对 Viking Therapeutics Inc 的 12 个月目标价中位数为 102.00 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nL4S3R1218:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","VKTX","BK4599","BK4585","BK4139"],"gpt_icon":0},{"id":"2529663915","title":"Viking Therapeutics Inc 報告截至 3 月 31 日的季度業績 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2529663915","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529663915?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 04:38","pubTimestamp":1745440681,"startTime":"0","endTime":"0","summary":"Viking Therapeutics Inc 报告截至 3 月 31 日的季度业绩 - 收益摘要Viking Therapeutics Inc VKTX.OQ报告，截至3月31日的季度调整后每股亏损41美分，低于去年同期的每股收益-26美分。Viking Therapeutics Inc 报告的季度每股收益为亏损 41 美分。该公司当季亏损 4563 万美元。Viking Therapeutics Inc 本季度股价上涨了 5.5%，今年迄今为止亏损了 36.7%。华尔街对 Viking Therapeutics Inc 的 12 个月目标价中位数为 102.00 美元。本摘要由 LSEG 4 月 23 日 08:37 p.m. UTC 调制解调器器生成。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nL4T3R1218:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4599","VKTX","BK4139","BK4585"],"gpt_icon":0},{"id":"2529657721","title":"市場消息：輝瑞公司在2025年美國臨牀腫瘤學會年會上提出癌症治療未來的大膽願景。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529657721","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529657721?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 03:48","pubTimestamp":1745437717,"startTime":"0","endTime":"0","summary":"市场消息：辉瑞公司在2025年美国临床肿瘤学会年会上提出癌症治疗未来的大胆愿景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/24034849811020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0456855351.SGD","LU0306807586.USD","LU1066051498.USD","LU0985481810.HKD","SG9999011175.SGD","IE00BLSP4452.SGD","BK4585","BK4599","LU1894683264.USD","LU1057294990.SGD","SG9999001176.USD","SGXZ57979304.SGD","IE00BBT3K403.USD","LU1894683348.USD","BK4581","BK4533","BK4534","BK4588","LU0306806265.USD","IE00B19Z3B42.SGD","LU1883839398.USD","SG9999001176.SGD","BK4007","LU0225284248.USD","LU0868494617.USD","IE00B19Z3581.USD","SG9999013999.USD","IE000M9KFDE8.USD","BK4550","IE00BLSP4239.USD","IE0002270589.USD","LU0225771236.USD","LU1066053197.SGD","LU0321505439.SGD","LU0234572021.USD","SG9999002224.SGD","LU0170899867.USD","LU0289739699.SGD","BK4568","SG9999003800.SGD","LU1023059063.AUD","LU0122379950.USD","PFE","BK4592","SG9999002232.USD","LU0321505868.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"2529856665","title":"全球製藥巨頭起訴藥企仿製其減肥神藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2529856665","media":"壹点飞讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529856665?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 00:08","pubTimestamp":1745424508,"startTime":"0","endTime":"0","summary":"全球制药巨头礼来公司周三宣布，已对四家复合药厂提起法律诉讼，指控其非法生产并销售含有替尔泊肽的未经批准复合药物。这是继上月美国法官禁止药房仿制其减肥药和糖尿病药物后，礼来在知识产权保护方面挥出的又一记重拳。礼来制药向加州法院对他们提起诉讼，主要指控其销售含有添加剂或口服剂型的替尔泊肽仿制药品，且无法提供安全性和有效性的临床证据。根据美国FDA规定，在药物被列为短缺期间，复合药厂可以合法仿制相关药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424043139a6c59b2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424043139a6c59b2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0882574055.USD","LU0289739699.SGD","LLY","LU0456855351.SGD","LU0079474960.USD","LU1548497426.USD","LU0471298694.HKD","LU1267930730.SGD","LU2237443549.SGD","SG9999015978.USD","LU1988902786.USD","LU0672654240.SGD","IE00BK4W5M84.HKD","LU1868837136.USD","LU2237438978.USD","LU2357305700.SGD","LU2602419157.SGD","BK4581","LU0689472784.USD","LU0203202063.USD","LU0882574139.USD","SG9999015952.SGD","SGXZ81514606.USD","LU1551013342.USD","LU0238689110.USD","IE00B2B36J28.USD","SG9999017495.SGD","LU0096364046.USD","LU1061106388.HKD","LU2265009873.SGD","LU1291159041.SGD","LU0198837287.USD","LU1868837300.USD","LU0354030511.USD","LU0109391861.USD","IE0002141913.USD","LU2089984988.USD","IE00BJT1NW94.SGD","LU1280957306.USD","LU2112291526.USD","LU2471134952.CNY","LU0094547139.USD","BK4599","LU0256863902.USD","LU2361045086.USD","SG9999014880.SGD","LU0203201768.USD","LU2106854487.HKD","BK4516","LU0256863811.USD"],"gpt_icon":1},{"id":"2529631052","title":"斯洛伐克總理暫停購買 COVID-19 疫苗，等待審查","url":"https://stock-news.laohu8.com/highlight/detail?id=2529631052","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529631052?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 23:34","pubTimestamp":1745422499,"startTime":"0","endTime":"0","summary":"斯洛伐克总理暂停购买 COVID-19 疫苗，等待审查路透4月23日 - 斯洛伐克总理罗伯特-菲佐表示，斯洛伐克政府已于周三停止采购 COVID-19 疫苗，等待斯洛伐克科学院对其安全性进行审查。科特拉尔在没有证据的情况下声称基于 mRNA 技术的疫苗不安全，并呼吁政府停止接种。菲佐曾多次怀疑接种COVID-19疫苗的好处，并在大流行期间组织了一次违反封锁规定的抗议活动。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nL4S3R11OY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","LU0234572021.USD","LU1066051498.USD","LU0225284248.USD","LU0456855351.SGD","LU0225771236.USD","IE00BLSP4452.SGD","BK4592","LU0170899867.USD","SG9999003800.SGD","SG9999001176.SGD","LU1057294990.SGD","BK4532","LU1894683348.USD","LU0058720904.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","MRNA","BK4599","IE0002270589.USD","BK4548","LU1066053197.SGD","LU0306807586.USD","SG9999002224.SGD","SG9999011175.SGD","IE00B19Z3581.USD","BK4533","BK4550","SG9999013999.USD","BK4007","LU1894683264.USD","BK4551","LU0122379950.USD","LU0306806265.USD","BK4534","LU1883839398.USD","LU0289739699.SGD","LU0868494617.USD","LU0321505439.SGD","LU0321505868.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","BK4585","BK4581","BK4501","BK4588","LU0985481810.HKD","BK4568"],"gpt_icon":1},{"id":"2529268009","title":"碩迪生物盤中異動 股價大漲5.03%報24.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529268009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529268009?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 22:10","pubTimestamp":1745417434,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日22时10分，硕迪生物股票出现波动，股价大幅上涨5.03%。截至发稿，该股报24.20美元/股，成交量15.5897万股，换手率0.27%，振幅4.26%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.23亿美元，每股收益-2.33美元，毛利-2.60百万美元，市盈率-10.31倍。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为1.21%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423221034aa2c78f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423221034aa2c78f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"2529638207","title":"Viking Therapeutics, Inc.盤中異動 早盤急速拉昇5.02%報26.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529638207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529638207?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 21:52","pubTimestamp":1745416324,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时52分，Viking Therapeutics, Inc.股票出现波动，股价急速拉升5.02%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Ensysce Biosciences, Inc.、Silexion Therapeutics Corp、Instil Bio, Inc.涨幅较大，Ensysce Biosciences, Inc.、Silexion Therapeutics Corp、Ocean Biomedical, Inc.较为活跃，换手率分别为4635.83%、102.55%、28.99%，振幅较大的相关个股有Fortress Biotech Inc 9.375% Cum Red Per Pref Ser A Usd25.00、Silexion Therapeutics Corp、Ensysce Biosciences, Inc.，振幅分别为101.45%、59.90%、52.94%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423215205aa2c78d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423215205aa2c78d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4007","VKTX","BK4585","LENZ","BK4599"],"gpt_icon":0},{"id":"2529631611","title":"諾和諾德盤中異動 股價大漲3.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529631611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529631611?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 21:33","pubTimestamp":1745415201,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时33分，诺和诺德股票出现异动，股价快速拉升3.66%。诺和诺德股票所在的制药行业中，整体涨幅为0.83%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。消息层面，截至21时33分，《减肥药双雄死磕口服新战场减肥药双雄死磕口服新战场》资讯为影响诺和诺德的重要信息。结果公布后，诺和诺德计划在2023年提交上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213321a463fa08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213321a463fa08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","BK4007","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4599","NVO","LU1093756325.SGD","BK4532","BK4588","LU1093756168.USD","BK4585"],"gpt_icon":1},{"id":"2529922689","title":"Altimmune, Inc.盤中異動 急速拉昇5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529922689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529922689?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 21:31","pubTimestamp":1745415072,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时31分，Altimmune, Inc.股票出现波动，股价大幅拉升5.57%。截至发稿，该股报5.12美元/股，成交量5.5037万股，换手率0.07%，振幅0.41%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213112a463f911&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213112a463f911&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4139","ALT","LU1878469433.USD"],"gpt_icon":0},{"id":"2529251860","title":"諾和諾德4月22日成交額為6.98億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529251860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529251860?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 10:11","pubTimestamp":1745374270,"startTime":"0","endTime":"0","summary":"美东时间2025年4月22日，诺和诺德成交额为6.98亿美元，成交额较昨日减少10.34%，当日成交量为1169.79万股。诺和诺德于2025年4月22日涨2.71%，报59.91美元，该股过去5个交易日跌9.31%，年初至今跌29.52%，过去60日跌31.08%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423101111a4633c6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423101111a4633c6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0154236417.USD","LU1093756168.USD","LU1093756325.SGD","BK4585","BK4588","BK4007","BK4532","NVO"],"gpt_icon":1},{"id":"2529591552","title":"安進4月22日成交額為5.77億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529591552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529591552?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 09:15","pubTimestamp":1745370948,"startTime":"0","endTime":"0","summary":"美东时间2025年4月22日，安进成交额为5.77亿美元，成交额较昨日增加16.93%，当日成交量为208.10万股。安进于2025年4月22日涨1.72%，报278.4美元，该股过去5个交易日跌5.28%，年初至今涨7.68%，过去60日涨1.9%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423091602a6c47862&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423091602a6c47862&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4585","LU1023059063.AUD","LU1061106388.HKD","SG9999001440.SGD","AMGN","BK4139","LU2242646821.SGD","LU2242652126.USD","BK4581","BK4599","IE00BJJMRZ35.SGD","LU0058720904.USD","LU0122379950.USD","BK4533","LU1571399168.USD","BK4566","LU0289739699.SGD","IE00BJT1NW94.SGD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU1983299246.USD","IE0002141913.USD","LU1057294990.SGD","LU0109394709.USD","LU0889565916.HKD","IE00BFTCPJ56.SGD","LU2112291526.USD","IE0009355771.USD","LU0320765992.SGD","LU2089984988.USD","IE00B2B36J28.USD","LU0868494617.USD","BK4588"],"gpt_icon":0},{"id":"2529213530","title":"歐股“十一羅漢”收盤播報｜諾和諾德收跌超7.4%，歐萊雅則漲6.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529213530","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529213530?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 01:35","pubTimestamp":1745343302,"startTime":"0","endTime":"0","summary":"周二，阿斯麦控股荷兰阿姆斯特丹股价收跌0.55%，报561.10欧元。诺和诺德哥本哈根股价收跌7.43%，报390.00，逼近2022年9月23日底部365.30，2024年6月26日还曾涨至1033.20创盘中历史最高。德国思爱普Sap收跌3.32%，雀巢跌1.5%，罗氏跌0.31%，诺华、阿斯利康、LVMH集团、赛诺菲则至多收涨0.5%，葛兰素史克张1.93%，欧莱雅涨6.30%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230136379740f1a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230136379740f1a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LRLCY","BK4007","IE00BZ1G4Q59.USD","BK4599","IE00BKVL7J92.USD","LU1093756168.USD","BK4585","BK4588","LU0154236417.USD","BK4532","LU1093756325.SGD","NVO","BK4183"],"gpt_icon":0},{"id":"2529859539","title":"碩迪生物盤中異動 股價大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529859539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529859539?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 23:54","pubTimestamp":1745337275,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日23时54分，硕迪生物股票出现波动，股价快速下挫5.37%。截至发稿，该股报21.86美元/股，成交量52.9245万股，换手率0.92%，振幅5.80%。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为1.72%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422235435a462a96f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422235435a462a96f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4599","BK4007"],"gpt_icon":0},{"id":"2529721535","title":"明晟公司MSCI北歐國家指數微幅下跌，報326.01點，北歐醫療保健板塊領跌。諾和諾德跌7.4%，在一眾成分股裏表現最差。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529721535","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529721535?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 23:40","pubTimestamp":1745336434,"startTime":"0","endTime":"0","summary":"明晟公司MSCI北欧国家指数微幅下跌，报326.01点，北欧医疗保健板块领跌。诺和诺德跌7.4%，在一众成分股里表现最差。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/22234049770680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0154236417.USD","LU0320765059.SGD","LU0175139822.USD","LU1804176565.USD","LU0289739343.SGD","BK4007","BK4588","IE00BZ1G4Q59.USD","MSCI","LU0672654240.SGD","NVO","BK4585","LU0109391861.USD","LU1093756325.SGD","LU1093756168.USD","IE00BKVL7J92.USD","LU2265009873.SGD","LU2210149790.SGD","BK4532","LU1267930730.SGD","LU2210150020.SGD","LU0511384066.AUD","BK4599","LU0708995401.HKD","LU2095319765.USD","LU0289961442.SGD","BK4112","LU0289960550.SGD"],"gpt_icon":0},{"id":"2529535074","title":"Viking Therapeutics, Inc.盤中異動 快速上漲5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529535074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529535074?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 23:32","pubTimestamp":1745335945,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日23时32分，Viking Therapeutics, Inc.股票出现异动，股价急速拉升5.02%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.80%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422233225a462a4e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422233225a462a4e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4599","LENZ","BK4007","BK4139","VKTX"],"gpt_icon":0},{"id":"2529580968","title":"諾和諾德盤中異動 股價大漲3.00%報60.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529580968","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529580968?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 22:46","pubTimestamp":1745333167,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日22时46分，诺和诺德股票出现异动，股价大幅拉升3.00%。截至发稿，该股报60.08美元/股，成交量487.427万股，换手率0.11%，振幅1.95%。诺和诺德股票所在的制药行业中，整体涨幅为0.34%。诺和诺德公司简介：诺和诺德拥有全球约三分之一的品牌糖尿病治疗市场，是全球领先的糖尿病护理产品供应商。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422224607a4629ae8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422224607a4629ae8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IE00BKVL7J92.USD","BK4007","NVO","LU1093756168.USD","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4585","BK4532","BK4599"],"gpt_icon":1},{"id":"2529399800","title":"“減肥神藥”邁向口服時代！諾和諾德申請美國批准口服版Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=2529399800","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529399800?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 15:40","pubTimestamp":1745307641,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺和诺德今年早些时候向美国FDA提交了一份申请，寻求批准其重磅GLP-1减肥药Wegovy 的口服版本。诺和诺德在2023年5月公布了新型口服司美格鲁肽的3期积极数据。竞争对手礼来早些时候公布，其口服减肥药Orforglipron在三期临床试验中表现出色。服用Orforglipron的患者平均减轻16磅，相当于体重的7.9%。截至周一美股收盘，诺和诺德涨0.43%，礼来跌2.6%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282075.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"“减肥神药”迈向口服时代！诺和诺德申请美国批准口服版Wegovy","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0154236417.USD","BK4007","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4599","NVO","LU1093756325.SGD","BK4532","BK4588","LU1093756168.USD","BK4585"],"gpt_icon":0},{"id":"2529958348","title":"諾和諾德股價下跌9.8%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529958348","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529958348?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 15:07","pubTimestamp":1745305638,"startTime":"0","endTime":"0","summary":"诺和诺德股价下跌9.8%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/22150749745536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0154236417.USD","BK4007","BK4599","LU1093756325.SGD","NVO","IE00BKVL7J92.USD","BK4585","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4532","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":5,"totalSize":121,"code":"91000000","status":"200"}]}}